Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 2.7
Power Rank trend -> Rising
Industry: Healthcare Plans
Follow @stockchartsai on TwitterIn the past 20 trading days, CI has been trading in a range between $285.03 and $274.49 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
The AI powered stock chart is in a Red zone currently. We would avoid this stock.
Cigna Corp $CI entered a Red zone 78 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $395.7275, a potential upside of 39.35% from the recent price of 283.99. The stock is trading 30.03% (potential upside) below its 52 week high of $369.28 and 8.38 % (potential downside) above its 52 week low of $262.03 - based on the recent price.
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations.
Cigna: Buy The Drop On This Undervalued Growth Stock Cigna's current valuation presents a compelling opportunity, trading at a forward PE of 9.9, significantly below its historical average of 12.0x. The company carries diversified revenue streams and consistent earnings growth, with Healthcare and Evernorth divisions driving strong performance and a 13% EPS CAGR over 10 years. Management targets 10-14% long-term annual EPS growth, supported by increased biosimilar adoption, behavioral health services growth, and aggressive share buybacks. Source: Seeking Alpha Sat, 18 Jan 2025 11:30:00 -0500 Sentiment: Positive |
Focus On Costs, Regulatory Outlook For Health Insurers In Q4'24 Earnings Season Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-side analyst forecasts. Coming off a challenging end to 2024, the upcoming earnings season is an opportunity for managed care companies to focus on 2025 expectations and Medicare Advantage growth, according to J.P. Morgan analyst Lisa Gill. UnitedHealth and Oscar Health are expected to log sequential and year-over-year revenue growth. Source: Seeking Alpha Thu, 16 Jan 2025 10:50:00 -0500 Sentiment: Negative |
FTC Report Reveals PBM Practices Impacting Competition and Drug Costs The report comes at a time when insurers are grappling with rising medical costs. Source: Zacks Investment Research Wed, 15 Jan 2025 11:31:15 -0500 Sentiment: Negative |
The Cigna Group's Fourth Quarter 2024 Earnings Release Details BLOOMFIELD, Conn. , Jan. 14, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January 30, 2025, and will host a conference call the same day. Source: PRNewsWire Tue, 14 Jan 2025 09:00:00 -0500 Sentiment: Neutral |
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services BLOOMFIELD, Conn. , Jan. 13, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), today announced a new offering in collaboration with Progyny, Inc (Nasdaq: PGNY) that makes best-in-class fertility and family-building services accessible and equitable for more employers. Source: PRNewsWire Mon, 13 Jan 2025 08:00:00 -0500 Sentiment: Neutral |
Stock Analyzed Each Night
Easily Upload Track Your Stocks
See Lists of Stocks Starting New Trends
The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.